drugset / Trial / NCT01171690

Teriparatide for Postsurgical Hypoparathyroidism

NCT01171690

Phase 2 Terminated 5 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

This study evaluated the effects of teriparatide (Forteo) on low calcium levels in the setting of thyroid surgery associated with low parathyroid hormone. The hypothesis was that teriparatide ( Forteo) would shorten the length of hospitalization post thyroidectomy in patients with symptomatic hypoparathyroidism.

Timeline

Start
2010-11
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug